1. Status of Implementation and Maintenance/Governance Plans
December 2017

2. Status of Implementation
Over 4,300 Downloads of the CPT from TransCelerate website through November 2017!
Member companies, other sponsors, academic institutions, major cancer centers health authorities. Across all major global regions.
15 Member Companies are implementing CPT.
Implementation Status Reported via Public Survey:
Study Phases using CPT
I, II, III, IV
Geographies where CPT is used
N America, S America, UK, Europe, Japan, China, Asia Pacific, Africa/Middle East
Therapeutic Areas where CPT is used
Cardiovascular, Dermatology, Gastroenterology, Immunology, Infectious Diseases, Metabolic Disorders, Neuroscience, Oncology, Ophthalmology, Respiratory, Urology, Vaccines, Women’s Health, Devices
Health Authority comments on CPT text/format
95% no comment; 5% comment(n=1);
0% rejected/mandatory revisions due to CPT text/format
IRB/ERC comments on CPT text/format
100% no comment; 0% comment;
Legally approved 8-Apr-2017

3. CPT Maintenance/Governance Plans
Governance Model being refined
Posted Template & Implementation Toolkit
Ongoing Maintenance & Governance of Template
Collect and report metrics and feedback
Updates to the templates and libraries
Update of the template and libraries as needed based on stakeholder feedback, regulatory guidance etc.
Additional TA libraries
Metrics to monitor extent of adoption, regulator feedback
Metrics to assess efficiencies gained
Feedback collected via the TransCelerate website
Legally approved 8-Apr-2017

4. Testimonials and Value Stories
See the additional Toolkit Resource “CPT Testimonials and Value Stories” for recent feedback from the CPT Community, including:
Benefits realized by companies who have already adopted CPT
Reactions to the template from internal teams (Sponsor) and external users
Tips for organizations considering adopting CPT
An example of a Sponsor CPT journey

5. Thank you